Planta Med 2002; 68(12): 1092-1096
DOI: 10.1055/s-2002-36338
Original Paper
© Georg Thieme Verlag Stuttgart · New York

Kavalactones and Dihydrokavain Modulate GABAergic Activity in a Rat Gastric-Brainstem Preparation

Chun-Su Yuan1, 2, 3 , Lucy Dey1, 3 , Anbao Wang1, 3 , Sangeeta Mehendale1, 3 , Jing-Tian Xie1, 3 , Han H. Aung1, 3 , Michael K. Ang-Lee3
  • 1Tang Center for Herbal Medicine Research, The Pritzker School of Medicine, University of Chicago, Chicago, U.S.A.
  • 2Committee on Clinical Pharmacology, The Pritzker School of Medicine, University of Chicago, Chicago, U.S.A.
  • 3Department of Anesthesia & Critical Care, The Pritzker School of Medicine, University of Chicago, Chicago, U.S.A.
Further Information

Publication History

Received: March 8, 2002

Accepted: June 29, 2002

Publication Date:
20 December 2002 (online)


Using an in vitro neonatal rat gastric-brainstem preparation, the activity of majority neurons recorded in the nucleus tractus solitarius (NTS) of the brainstem were significantly inhibited by GABAA receptor agonist, muscimol (30 μM), and this inhibition was reversed by selective GABAA receptor antagonist, bicuculline (10 μM). Application of kavalactones (300 μg/ml) and dihydrokavain (300 μM) into the brainstem compartment of the preparation also significantly reduced the discharge rate of these NTS neurons (39 % and 32 %, respectively, compared to the control level), and this reduction was partially reversed by bicuculline (10 μM). Kavalactones or dihydrokavain induced inhibitory effects were not reduced after co-application of saclofen (10 μM; a selective GABAB receptor antagonist) or naloxone (100 nM; an opioid receptor antagonist). Pretreatment with kavalactones (300 μg/ml) or dihydrokavain (300 μM) significantly decreased the NTS inhibitory effects induced by muscimol (30 μM), approximately from 51 % to 36 %. Our results demonstrated modulation of brainstem GABAergic mechanism by kavalactones and dihydrokavain, and suggested that these compounds may play an important role in regulation of GABAergic neurotransmission.


  • 1 Volz H P, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders - a randomized placebo-controlled 25-week outpatient trial.  Pharmacopsychiatry. 1997;  30 1-5
  • 2 Pittler M H, Ernst E. Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis.  Journal of Clinical Psychopharmacology. 2000;  20 84-9
  • 3 Robbers J E, Tyler V E. Nervous system disorders. In: Tyler’s Herbs of Choice. New York; Haworth Press, Inc 1999: 154-7
  • 4 Ang-L. M K, Moss J, Yuan C S. Herbal medicines and perioperative care.  JAMA. 2001;  286 208-16
  • 5 Singh Y N. Kava: An overview.  Journal of HerbalGram. 1997;  39 33-55
  • 6 Davies L P, Drew C A, Duffield P, Johnston G A, Jamieson D D. Kava pyrones and resin: Studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain.  Pharmacology & Toxicology. 1992;  71 120-6
  • 7 Bormann J, Feigenspan A. GABAC receptors.  Trends in Neurosciences. 1995;  18 515-9
  • 8 Johnston G A. GABAC receptors: Relatively simple transmitter-gated ion channels?.  Trends in Pharmacological Sciences. 1996;  17 319-23
  • 9 Maley B E. Immunohistochemical localization of neuropeptides and neurotransmitters in the nucleus solitarius.  Chemical Senses. 1996;  21 367-76
  • 10 Ruggeri P, Cogo C E, Picchio V, Molinari C, Ermirio R, Calaresu F R. Influence of GABAergic mechanisms on baroreceptor inputs to nucleus tractus solitarii of rats.  American Journal of Physiology. 1996;  271 931-6
  • 11 Shao X M, Feldman J L. Respiratory rhythm generation and synaptic inhibition of expiratory neurons in pre-Botzinger complex: Differential roles of glycinergic and GABAergic neural transmission.  Journal of Neurophysiology . 1997;  77 1853-60
  • 12 Yuan C S, Liu D, Attele A S. GABAergic effects on nucleus tractus solitarius neurons receiving gastric vagal inputs.  Journal of Pharmacology and Experimental Therapeutics . 1998;  286 736-41
  • 13 Yuan C S, Attele A S, Dey L, Xie J T. Gastric effects of cholecystokinin and its interaction with leptin on brain stem neuronal activity.  Journal of Pharmacology and Experimental Therapeutics. 2000;  295 177-82
  • 14 Smith R M. High-performance liquid chromatography of kava lactones from Piper methysticum .  Journal of Chromatography.. 1984;  283 303-8
  • 15 Smith K K, Dharmaratne H RW, Feltenstein M W, Broom S L, Roach J T, Nanayakkara N PD, Khan I A, Sufka K J. Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm.  Psychopharmacology. 2001;  155 86-90
  • 16 Pepping J. Kava: Piper methysticum .  American Journal of Health System and Pharmarcy. 1999;  56 957-60
  • 17 Dinh L D, Simmen U, Bueter K B, Bueter B, Lundstrom K, Schaffner W. Interaction of various Piper methysticum cultivars with CNS receptors in vitro .  Planta Medica. 2001;  67 306-11
  • 18 Cooper J R, Blorr F E, Roth R H. The Biochemical Basis of Neuropharmacology. Oxford University Press New York; 1986
  • 19 Russmann S, Lauterburg B H, Helbling A. Kava hepatotoxicity.  Annals of Internal Medicine . 2001;  35 68-9
  • 20 Escher M, Desmeules J, Giostra E, Mentha G. Hepatitis associated with kava, a herbal remedy for anxiety.  British Medical Journal. 2001;  322 139

Chun-Su Yuan, MD PhD

Department of Anesthesia & Critical Care

The Pritzker School of Medicine

University of Chicago

5841 S. Maryland Avenue, MC 4028

Chicago, Illinois 60637


Phone: +1-773-702-1916

Fax: +1-773-834-0601